Andres Y. Maldonado Analyst PerformanceBiotechnology Equity Research Analyst at HC WainwrightAndres Y. Maldonado is a stock analyst at HC Wainwright in the healthcare sector, covering 25 publicly traded companies. Over the past year, Andres Y. Maldonado has issued 61 stock ratings, including buy and hold recommendations. While full access to Andres Y. Maldonado's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andres Y. Maldonado's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings62 Last 1 YearsBuy Recommendations93.55% 58 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution62RatingsDistribution of strong buy, buy, hold, and sell ratings by Andres Y. Maldonado.RatingPercentageCount Strong Buy0.0%0 ratings Buy93.5%58 ratings Hold6.5%4 ratings Sell0.0%0 ratingsOut of 62 total stock ratings issued by Andres Y. Maldonado at HC Wainwright, the majority (93.5%) have been Buy recommendations, followed by 6.5% Hold.Best & Worst CallsBest Call000.0%KROSAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ25 companiesAndres Y. Maldonado, an analyst at HC Wainwright, currently covers 25 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare25 companies100.0%Andres Y. Maldonado of HC Wainwright specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY24 companies96.0%PHARMACEUTICALS1 company4.0% Andres Y. Maldonado's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsERASErasca8/12/2026Boost Price Target$18.31$22.00Buy$0.0000.00% ROITCRXTScan Therapeutics8/12/2026Reiterated Rating$0.76Buy$0.0000.00% ROIAURAAura Biosciences8/11/2026Lower Price Target$7.75$18.00Buy$0.0000.00% ROICRBPCorbus Pharmaceuticals8/7/2026Lower Price Target$9.74$35.00Buy$0.0000.00% ROIIMRXImmuneering8/6/2026Initiated Coverage$4.39$14.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals8/5/2026Lower Price Target$19.08$38.00Buy$0.0000.00% ROIMNPRMonopar Therapeutics7/22/2026Boost Price Target$112.57$125.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals7/15/2026Reiterated Rating$24.13$40.00Buy$0.0000.00% ROIMNPRMonopar Therapeutics6/29/2026Reiterated Rating$87.68$105.00Buy$0.0000.00% ROIVSTMVerastem6/24/2026Reiterated Rating$4.21$18.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RLMDRelmada Therapeutics6/18/2026Initiated Coverage$6.60$12.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals6/12/2026Reiterated Rating$17.91$40.00Buy$0.0000.00% ROIIBRXImmunityBio6/2/2026Reiterated Rating$7.24$15.00Buy$0.0000.00% ROICRBPCorbus Pharmaceuticals5/26/2026Reiterated Rating$8.30$40.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals5/22/2026Reiterated Rating$19.77$40.00Buy$0.0000.00% ROIIBRXImmunityBio5/20/2026Reiterated Rating$7.76$15.00Buy$0.0000.00% ROICGONCG Oncology5/18/2026Reiterated Rating$66.93$100.00Buy$0.0000.00% ROISTROSutro Biopharma5/15/2026Boost Price Target$38.42$50.00Buy$0.0000.00% ROIIMNMImmunome5/13/2026Reiterated Rating$22.69$40.00Buy$0.0000.00% ROISRRKScholar Rock5/8/2026Boost Price Target$46.45$65.00Buy$0.0000.00% ROIENGNenGene5/8/2026Lower Price Target$1.72$6.00Buy$0.0000.00% ROIVSTMVerastem4/10/2026Reiterated Rating$5.38$18.00Buy$0.0000.00% ROINBPI-Mab4/8/2026Reiterated Rating$2.48$9.00Buy$0.0000.00% ROICGONCG Oncology4/7/2026Boost Price Target$67.55$100.00Buy$0.0000.00% ROIAURAAura Biosciences3/30/2026Reiterated Rating$6.31$22.00Buy$0.0000.00% ROITERNTerns Pharmaceuticals3/25/2026Reiterated Rating$52.76$53.00Neutral$0.0000.00% ROISTROSutro Biopharma3/24/2026Upgrade$21.33$28.00Buy$0.0000.00% ROINBPI-Mab3/16/2026Reiterated Rating$2.85$9.00Buy$0.0000.00% ROIERASErasca3/13/2026Boost Price Target$14.65$20.00Buy$0.0000.00% ROIFHTXFoghorn Therapeutics3/10/2026Reiterated Rating$5.48$13.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals3/10/2026Reiterated Rating$21.33$21.50Neutral$0.0000.00% ROIENGNenGene3/9/2026Reiterated Rating$7.38$25.00Buy$0.0000.00% ROISRRKScholar Rock3/3/2026Reiterated Rating$45.83$58.00Buy$0.0000.00% ROICGONCG Oncology2/27/2026Boost Price Target$59.09$80.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals2/25/2026Lower Price Target$12.02$22.00Buy$0.0000.00% ROIIMNMImmunome2/12/2026Initiated Coverage$23.41$40.00Buy$0.0000.00% ROITARAProtara Therapeutics2/10/2026Reiterated Rating$6.48$23.00Buy$0.0000.00% ROIERASErasca1/26/2026Boost Price Target$9.96$15.00Buy$0.0000.00% ROIIBRXImmunityBio1/26/2026Boost Price Target$6.45$10.00Buy$0.0000.00% ROIERASErasca1/13/2026Boost Price Target$6.23$11.00Buy$0.0000.00% ROITrump's Next Move Could Shrink Your Dollar (Ad)There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. dollar through tariffs, currency pressure, and coordinated policy shifts designed to boost American exports. A weaker dollar means every dollar you've saved buys less - quietly, without a headline or a warning. Smart investors are already repositioning before the slide accelerates.Discover 3 strategies to protect your wealth from a falling dollarSTROSutro Biopharma12/22/2025Boost Price Target$9.98$10.00Neutral$0.0000.00% ROIHOWLWerewolf Therapeutics12/19/2025Lower Price Target$0.65$4.00Buy$0.0000.00% ROITARAProtara Therapeutics12/3/2025Reiterated Rating$6.71$23.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals11/24/2025Reiterated Rating$9.03$25.00Buy$0.0000.00% ROITARAProtara Therapeutics11/19/2025Reiterated Rating$6.21$23.00Buy$0.0000.00% ROITCRXTScan Therapeutics11/13/2025Lower Price Target$1.19$7.00Buy$0.0000.00% ROITERNTerns Pharmaceuticals11/4/2025Upgrade$14.03$20.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals10/27/2025Reiterated Rating$13.53$40.00Buy$0.0000.00% ROICRBPCorbus Pharmaceuticals10/20/2025Reiterated Rating$19.32$40.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals10/16/2025Initiated Coverage$15.04$40.00Buy$0.0000.00% ROIMRUSMerus9/29/2025Downgrade$93.71$97.00Neutral$0.0000.00% ROICADLCandel Therapeutics9/29/2025Reiterated Rating$5.38$23.00Buy$0.0000.00% ROISRRKScholar Rock9/23/2025Lower Price Target$32.37$44.00Buy$0.0000.00% ROICRBPCorbus Pharmaceuticals9/17/2025Reiterated Rating$10.27$40.00Buy$0.0000.00% ROICGONCG Oncology9/15/2025Reiterated Rating$33.34$75.00Buy$0.0000.00% ROIIBRXImmunityBio9/10/2025Reiterated Rating$2.57$8.00Buy$0.0000.00% ROIENGNenGene9/8/2025Reiterated Rating$5.18$25.00Buy$0.0000.00% ROICGONCG Oncology9/5/2025Reiterated Rating$32.52$75.00Buy$0.0000.00% ROIMNPRMonopar Therapeutics8/26/2025Initiated Coverage$30.42$70.00Buy$0.0000.00% ROIIMABI-Mab8/21/2025Reiterated Rating$4.52$7.00Buy$0.0000.00% ROIAURAAura Biosciences8/13/2025Reiterated Rating$7.21$22.00Buy$0.0000.00% ROIKROSKeros Therapeutics8/8/2025Lower Price Target$13.36$20.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageThe Goldman Sachs GroupTD CowenDeutsche Bank AktiengesellschaftWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupTruist FinancialPiper SandlerBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
